Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,497,077 papers from all fields of science
Search
Sign In
Create Free Account
oncostatin M
Known as:
OSM
, Oncostatin M [Chemical/Ingredient]
, Oncostatin-M
A cytokine with both pro- and anti-inflammatory actions that depend upon the cellular microenvironment. Oncostatin M is a 28 kDa monomeric…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
18 relations
Broader (2)
Antineoplastic Agents
Growth Inhibitors
Cell Proliferation
Cytokine Gene
Cytokine Receptor Binding
Cytokine Signaling
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
C. Hintzen
,
S. Quaiser
,
T. Pap
,
P. Heinrich
,
H. Hermanns
Arthritis & Rheumatism
2009
Corpus ID: 33035924
OBJECTIVE To investigate the molecular mechanisms of CCL13/monocyte chemoattractant protein 4 (MCP-4) chemokine expression…
Expand
2006
2006
Divergent effects of oncostatin M on astroglioma cells: Influence on cell proliferation, invasion, and expression of matrix metalloproteinases
Shao-Hua Chen
,
G. Gillespie
,
Etty N. Benveniste
Glia
2006
Corpus ID: 43415087
Oncostatin M (OSM), a cytokine of the interleukin‐6 (IL‐6) family, can either promote or inhibit cell growth in various normal…
Expand
2004
2004
Cytokines regulate the affinity of soluble CD44 for hyaluronan
J. Cichy
,
E. Puré
FEBS Letters
2004
Corpus ID: 21955550
Highly Cited
2003
Highly Cited
2003
Oncostatin M Regulates Eotaxin Expression in Fibroblasts and Eosinophilic Inflammation in C57BL/6 Mice1
C. Langdon
,
C. Kerr
,
L. Tong
,
C. Richards
Journal of Immunology
2003
Corpus ID: 6100473
Oncostatin M (OSM) is a member of the IL-6/LIF (or gp130) cytokine family, and its potential role in inflammation is supported by…
Expand
Highly Cited
2000
Highly Cited
2000
Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
C. Richards
,
C. Langdon
,
Paula A. Deschamps
,
D. Pennica
,
S. Shaughnessy
Cytokine
2000
Corpus ID: 29501645
The role of oncostatin M in bone metabolism is not clearly defined, and the actions of mouse oncostatin M (mOSM) on osteoclast…
Expand
Highly Cited
1999
Highly Cited
1999
Blocking signaling through the gp130 receptor chain by interleukin‐6 and oncostatin M inhibits PC‐3 cell growth and sensitizes the tumor cells to etoposide and cisplatin‐mediated cytotoxicity
N. Borsellino
,
B. Bonavida
,
G. Ciliberto
,
C. Toniatti
,
S. Travali
,
N. D’alessandro
Cancer
1999
Corpus ID: 25098793
The mechanisms of drug resistance associated with advanced, hormone‐independent prostate carcinoma are poorly understood. The…
Expand
1999
1999
Adenovirus vector expressing mouse oncostatin M induces acute-phase proteins and TIMP-1 expression in vivo in mice.
C. Kerr
,
C. Langdon
,
F. Graham
,
J. Gauldie
,
T. Hara
,
C. Richards
Journal of Interferon and Cytokine Research
1999
Corpus ID: 12260621
Mouse oncostatin M (MuOSM) regulates the production of acute-phase proteins by hepatocytes as well as tissue inhibitor of…
Expand
Highly Cited
1997
Highly Cited
1997
Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro.
C. Langdon
,
Jonathon Leith
,
Carl D. Richards
,
Frcs Frank Smith
Arthritis & Rheumatism
1997
Corpus ID: 19613496
OBJECTIVE To measure levels of oncostatin M (OSM) in the synovial fluid of rheumatoid arthritis (RA) patients and to examine the…
Expand
1996
1996
Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.
W. Hui
,
M. Bell
,
G. Carroll
Cytokine
1996
Corpus ID: 23903417
Oncostatin M (OSM) is structurally and functionally similar to leukaemia inhibitory factor (LIF), interleukin 6 (IL-6…
Expand
1995
1995
The gp 130 family cytokines IL‐6, LIF and OSM but not IL‐11 can reverse the anti‐proliferative effect of dexamethasone on human myeloma cells
N. Juge-Morineau
,
S. François
,
D. Puthier
,
A. Godard
,
R. Bataille
,
M. Amiot
British Journal of Haematology
1995
Corpus ID: 28187761
Summary. In order to understand the mechanisms supporting steroid escape in patients with multiple myeloma (MM), three IL‐6…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE